Question 1

What is the Onyx Biotec Limited IPO?

Accepted Answer

The Onyx Biotec Limited IPO is an SME (Small and Medium Enterprise) Initial Public Offering where Onyx Biotec Limited is offering its shares to the public for the first time. The issue size is ₹48 lakhs with a price band of ₹58-61. This allows retail and institutional investors to become shareholders in the company.

Question 2

When will Onyx Biotec Limited IPO open?

Accepted Answer

The Onyx Biotec Limited IPO was open from 13 November 2024 to 18 November 2024. The subscription period has now ended.

Question 3

What is the lot size of Onyx Biotec Limited IPO?

Accepted Answer

The lot size for Onyx Biotec Limited IPO is 2000 shares, which means the minimum investment required is approximately ₹1,22,000 (2000 shares × ₹58-61). Retail investors can apply for one or more lots, but applying for a single lot typically gives better allotment chances during oversubscription.

Question 4

How to apply for Onyx Biotec Limited IPO?

Accepted Answer

You can apply for the Onyx Biotec Limited IPO through multiple channels: 1) Online broker platforms like Zerodha, Groww, Angel One, Upstox (most convenient); 2) Internet banking using ASBA facility; 3) Through your bank branch. You'll need a Demat account, linked bank account, PAN card, and sufficient funds. The application process involves selecting the IPO, choosing number of lots, selecting bid price (or cutoff), and authorizing the payment via UPI mandate.

Question 5

When is Onyx Biotec Limited IPO allotment?

Accepted Answer

The Onyx Biotec Limited IPO allotment was completed on Expected 5-7 days after closing. You can check your allotment status on the registrar's website (Link Intime, KFintech, or Bigshare) using your PAN number, application number, or Demat details. Allotted shares will be credited to your Demat account before the listing date. If you don't get allotment, your blocked amount will be unblocked automatically.

Question 6

When is Onyx Biotec Limited IPO listing date?

Accepted Answer

The Onyx Biotec Limited IPO was listed on 22 November 2024. On listing day, shares will start trading on the stock exchanges, and you can sell your allotted shares or hold them for long-term investment based on your strategy. Listing price depends on market demand and may be above, below, or at the issue price.

Question 7

Was GMP of Onyx Biotec Limited IPO reliable?

Accepted Answer

The Grey Market Premium (GMP) for Onyx Biotec Limited IPO was ₹5 before listing. The actual listing price was ₹54.05, giving a listing gain of -11.4% (₹-7 per share). The listing performance was lower than GMP suggested, showing that GMP was overestimated. This demonstrates that while GMP can be an indicator, it's not always accurate and should be used alongside fundamental analysis.

Question 8

How much profit have I made if I held Onyx Biotec Limited IPO after allotment?

Accepted Answer

If you were allotted shares at the issue price of ₹61 and held them until now, your current gain is -35.7% (₹-22 per share). For one lot of 2000 shares, your loss would be ₹44,000. On listing day, the stock opened at ₹54.05 (-11.4% gain). The stock performance has been relatively stable. Remember, past performance doesn't guarantee future results, and investment decisions should be based on the company's fundamentals and your investment goals.

Application	Lots	Shares	Amount
Individual(min) Individual Investors for SME IPO - Investment up to ₹2 lakhs (min 2 lots)	2	4,000	₹2.44L
Individual(max) Individual Investors for SME IPO - Investment up to ₹2 lakhs (min 2 lots)	2	4,000	₹2.44L
SHNI(min) Small HNI - Investment between ₹2 lakhs and ₹10 lakhs	3	6,000	₹3.66L
SHNI(max) Small HNI - Investment between ₹2 lakhs and ₹10 lakhs	8	16,000	₹9.76L
BHNI(min) Big HNI - Investment above ₹10 lakhs	9	18,000	₹10.98L

IPO Master

Onyx Biotec Limited

Market Performance

Stock Price Chart

Market Lot Size

IPO Timeline

IPO Opens

IPO Closes

Allotment

Listing

AI Research Analysis Not Available

Allotment Status

Frequently Asked Questions about Onyx Biotec Limited IPO